PL2707380T3 - Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów - Google Patents

Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów

Info

Publication number
PL2707380T3
PL2707380T3 PL12785572T PL12785572T PL2707380T3 PL 2707380 T3 PL2707380 T3 PL 2707380T3 PL 12785572 T PL12785572 T PL 12785572T PL 12785572 T PL12785572 T PL 12785572T PL 2707380 T3 PL2707380 T3 PL 2707380T3
Authority
PL
Poland
Prior art keywords
hmos
diversification
precursors
human milk
milk oligosaccharides
Prior art date
Application number
PL12785572T
Other languages
English (en)
Inventor
Gyula Dekany
Elise Champion
Andreas Schroven
Markus JONDELIUS HEDEROS
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2012/051314 external-priority patent/WO2012127410A1/en
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL2707380T3 publication Critical patent/PL2707380T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
PL12785572T 2011-05-13 2012-05-14 Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów PL2707380T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11166137 2011-05-13
PCT/IB2012/051314 WO2012127410A1 (en) 2011-03-18 2012-03-19 Synthesis of new fucose-containing carbohydrate derivatives
PCT/IB2012/052401 WO2012156898A1 (en) 2011-05-13 2012-05-14 DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF
EP12785572.4A EP2707380B1 (en) 2011-05-13 2012-05-14 DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF

Publications (1)

Publication Number Publication Date
PL2707380T3 true PL2707380T3 (pl) 2021-01-11

Family

ID=47176364

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12785572T PL2707380T3 (pl) 2011-05-13 2012-05-14 Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów

Country Status (14)

Country Link
US (2) US9382564B2 (pl)
EP (2) EP2707380B1 (pl)
JP (1) JP6106160B2 (pl)
KR (1) KR20140036226A (pl)
CN (1) CN103562214B9 (pl)
BR (1) BR112013029203A2 (pl)
CA (1) CA2835989A1 (pl)
DK (1) DK2707380T3 (pl)
ES (1) ES2820429T3 (pl)
IL (1) IL229047A0 (pl)
MX (1) MX349153B (pl)
PL (1) PL2707380T3 (pl)
RU (1) RU2013155453A (pl)
WO (1) WO2012156898A1 (pl)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2805499A1 (en) 2010-07-16 2012-01-19 Glycom A/S Derivatization of oligosaccharides
WO2013091660A1 (en) * 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
US20150320780A1 (en) * 2012-12-14 2015-11-12 Glycom A/S Mixture of fucosylate lactoses
GB201306689D0 (en) 2013-04-12 2013-05-29 Glycom As Synthesis of sialylated/fucosylated human milk oligosaccharides
BR112015025951A2 (pt) * 2013-04-12 2017-10-17 Univ Danmarks Tekniske sialidase mutante com atividade trans-sialidase, para uso em produção de glicanos sialilados
ES2891731T3 (es) 2013-05-22 2022-01-31 Glycom As Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
EP3041947A4 (en) 2013-09-06 2017-07-26 Glycom A/S Fermentative production of oligosaccharides
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
DK3209673T4 (da) 2014-10-24 2023-10-02 Glycom As Mixtures of human milk oligosaccharides
WO2016063261A1 (en) * 2014-10-24 2016-04-28 Glycom A/S Mutated fucosidase
EP3212198B1 (en) 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
WO2016066175A1 (en) 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN115350200A (zh) 2014-12-08 2022-11-18 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10588917B2 (en) * 2015-03-31 2020-03-17 Glycom A/S Mixtures of human milk oligosaccharides comprising 3 ′-O-sialyllactose
PL3307752T3 (pl) * 2015-06-09 2021-11-02 Glycom A/S Mieszaniny trójskładnikowe 6’-sl, lnnt i lst c
ES2798373T3 (es) 2015-06-09 2020-12-11 Glycom As Transsialidasas de photobacterium mutadas
WO2017021476A1 (en) 2015-08-04 2017-02-09 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
EP3349763B1 (en) 2015-09-14 2021-08-11 Glycom A/S Composition for use in microbiota modulation
ES2950489T3 (es) 2015-10-28 2023-10-10 Glycom As Composición sintética y método para modular los trastornos de la emoción y del ánimo
ES2927009T3 (es) * 2015-10-28 2022-10-31 Glycom As Composición sintética y método para modular la función cerebral y la conducta
ES2975018T3 (es) 2015-11-17 2024-07-02 Glycom As Oligosacáridos de la leche humana para el tratamiento de complicaciones asociadas a antibióticos
BR112018010505B1 (pt) 2015-12-15 2021-11-16 Société des Produits Nestlé S.A. Composições para bebês e crianças pequenas, e uso de uma mistura sintética de hmos
WO2017144062A1 (en) 2016-02-24 2017-08-31 Glycom A/S Synthetic composition for microbiota modulation
DK3452050T3 (da) 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
DK3452051T3 (en) 2016-05-05 2022-09-05 Glycom As COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN
US11224605B2 (en) 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
WO2017221208A1 (en) 2016-06-24 2017-12-28 Glycom A/S Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infections
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
US11278558B2 (en) 2017-03-01 2022-03-22 Glycom A/S Synthetic composition for microbiota modulation
US11291677B2 (en) 2017-05-09 2022-04-05 Glycom A/S Synthetic composition for microbiota modulation
WO2018215960A1 (en) 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising one or more human milk oligosaccharides (hmos)
US11541068B2 (en) 2017-05-24 2023-01-03 Glycom A/S HMO compositions and methods for reducing autism spectrum disorder symptoms
EP3645545A4 (en) 2017-06-30 2021-05-05 Glycom A/S PURIFICATION OF OLIGOSACCHARIDES
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
EP3450443A1 (en) * 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
CA3081496A1 (en) 2017-11-02 2019-05-09 Glycom A/S Mixture of hmos for reducing or preventing fatigue
JP7327724B2 (ja) 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ 小麦過敏症を処置するためのhmoの混合物
CN111556755A (zh) 2017-12-05 2020-08-18 格礼卡姆股份公司 用于治疗偏头痛的人乳寡糖
US11566219B2 (en) * 2017-12-08 2023-01-31 Morinaga Milk Industry Co., Ltd. Bifidobacterium bacteria and composition including novel bifidobacterium bacteria
WO2019123316A1 (en) 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception
EP3569713A1 (en) * 2018-05-16 2019-11-20 Jennewein Biotechnologie GmbH Use of glycosidases in the production of oligosaccharides
BR112020022892A2 (pt) 2018-05-31 2021-02-23 Glycom A/S mistura de hmos para tratamento de doenças autoi-munes
BR112021011071A2 (pt) 2018-12-19 2021-08-31 Glycom A/S Composição e método para o tratamento de seres humanos utilizando dietas com baixo teor de fodmap
CN110016066B (zh) * 2019-04-02 2021-11-02 江西师范大学 一种i型n-聚糖天线的合成方法
BR112022010061A2 (pt) 2019-11-29 2022-09-06 Glycom As Mistura de olhs para melhorar a microbiota das mulheres grávidas
CN112831510B (zh) * 2019-12-13 2022-04-22 中国科学院天津工业生物技术研究所 一株高效表达几丁质酶重组菌的构建及高酶活突变体的筛选
WO2022089707A1 (en) 2020-10-30 2022-05-05 Mille International Aps A method of producing a human milk oligosaccharide (hmo)
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
JP2023553548A (ja) 2020-12-04 2023-12-22 グリコム・アクティーゼルスカブ 睡眠パターンの成熟又は改善の支援に使用するためのヒト母乳オリゴ糖
WO2022223430A1 (en) 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
DK181242B1 (en) * 2021-05-17 2023-05-30 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME
CN113960232B (zh) * 2021-10-28 2024-02-20 苏州大学 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用
WO2023235555A1 (en) * 2022-06-02 2023-12-07 Bee-Io Honey Technologies Ltd. Cultured buffalo milk production methods, systems, compositions and uses thereof
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs
CN120018780A (zh) 2022-08-25 2025-05-16 帝斯曼知识产权资产管理有限公司 生产复杂hmo的混合方法
EP4623089A1 (en) 2022-11-25 2025-10-01 DSM IP Assets B.V. Two-strain system for producing oligosaccharides
DK182185B1 (en) 2022-12-14 2025-10-29 Dsm Ip Assets Bv Mutated lacto-n-biosidase,method for making the same and method for synthesizing lacto-n-biose containing carbohydrates
DK182217B1 (en) * 2024-04-11 2025-12-12 Dsm Ip Assets Bv Enzymatic n-acetyllactosaminylation of a terminal galactose in its 6-position
DK202430320A1 (en) 2024-06-13 2026-01-07 Dsm Ip Assets Bv Synthesis of branched chain oligosaccharides

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0586687A4 (en) * 1992-03-25 1996-04-17 Univ New York Trans-sialidase and methods of use and making thereof
JPH0686684A (ja) 1992-05-26 1994-03-29 Monsanto Co シアロ抱合体の合成
US5409817A (en) * 1993-05-04 1995-04-25 Cytel, Inc. Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
ES2180757T3 (es) 1995-04-11 2003-02-16 Neose Technologies Inc Sintesis enzimatica mejorada de oligosacaridos.
US6323008B1 (en) * 1997-08-14 2001-11-27 Neose Technologies, Inc. Methods for producing sialyloligosaccharides in a dairy source
AU2002330968B2 (en) 2001-08-17 2007-03-22 Neose Technologies, Inc. Chemo-enzymatic synthesis of sialylated oligosaccharides
MXPA06006392A (es) * 2003-12-05 2007-03-15 Childrens Hosp Medical Center Composiciones de oligosacaridos y uso de estas en el tratamiento de infecciones.
MX2007010094A (es) * 2005-02-21 2007-09-25 Nestec Sa Mezcla de oligosacarido.
JP4937288B2 (ja) 2009-03-02 2012-05-23 シャープ株式会社 画像読取装置及び画像形成装置
EP2536737B1 (en) * 2010-02-19 2017-05-31 Glycom A/S A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
CA2805499A1 (en) 2010-07-16 2012-01-19 Glycom A/S Derivatization of oligosaccharides
RU2013146524A (ru) 2011-03-18 2015-04-27 Глюком А/С Синтез новых фукозо-содержащих производных углеводородов

Also Published As

Publication number Publication date
MX349153B (es) 2017-07-14
EP3744725B1 (en) 2025-09-17
CA2835989A1 (en) 2012-11-22
CN103562214B (zh) 2016-10-19
US20140212930A1 (en) 2014-07-31
US9382564B2 (en) 2016-07-05
EP2707380A4 (en) 2014-10-08
KR20140036226A (ko) 2014-03-25
CN103562214B9 (zh) 2016-12-14
EP3744725C0 (en) 2025-09-17
BR112013029203A2 (pt) 2016-08-09
US9963729B2 (en) 2018-05-08
JP6106160B2 (ja) 2017-03-29
EP3744725A1 (en) 2020-12-02
WO2012156898A1 (en) 2012-11-22
US20160289721A1 (en) 2016-10-06
EP2707380A1 (en) 2014-03-19
RU2013155453A (ru) 2015-06-20
EP2707380B1 (en) 2020-07-08
JP2014513986A (ja) 2014-06-19
DK2707380T3 (da) 2020-10-12
ES2820429T3 (es) 2021-04-21
MX2013013027A (es) 2013-12-02
CN103562214A (zh) 2014-02-05
IL229047A0 (en) 2013-12-31

Similar Documents

Publication Publication Date Title
IL229047A0 (en) A shade of oligosaccharides of breast milk or their derivatives
IL229048A0 (en) A method for the production of oligosaccharides of breast milk or their derivatives
EP2706936A4 (en) SPECIFIC INSTRUMENTS OF A PATIENT
EP2779952A4 (en) HAMMER TOE IMPLANT
EP2696800A4 (en) POLYAXIAL DENTAL IMPLANT SYSTEM
GB201308746D0 (en) Patient Specific Implants
GB2479180B (en) System of user devices
GB201120345D0 (en) Medical console
ZA201308417B (en) Tissue healing
EP2691036A4 (en) SURGICAL ULTRASOUND INSTRUMENTS
EP2713914A4 (en) BONE WRIST
GB201000916D0 (en) Treatment of biofilms
GB201118588D0 (en) Device for disinfection of medical devices
EP2713960A4 (en) PATIENT-SPECIFIC INSTRUMENT
IL222328A (en) Tissue microabulation system
GB2489312B (en) Medical instrument
EP2687181A4 (en) SURGICAL SYSTEM
EP2638622A4 (en) CONNECTION FOR TWO-WIRE MEDICAL IMPLANT
EP2691034A4 (en) ULTRASONIC SURGICAL INSTRUMENTS
PL2544711T3 (pl) Leczenie zakażeń paciorkowcami
EP2543330A4 (en) MEDICAL TRAY
GB201015822D0 (en) Medical ruggedised case
IL232239A0 (en) Medical use
ZA201402633B (en) Treatment of chemical feedstocks
GB201306689D0 (en) Synthesis of sialylated/fucosylated human milk oligosaccharides